Top

BMC Infectious Diseases

Published in:

Open Access 01-12-2018 | Case report

A rare case of Aerococcus urinae infective endocarditis in an atypically young male: case report and review of the literature

Authors: Joseph M. Yabes, Serafim Perdikis, David B. Graham, Ana Markelz

Published in: BMC Infectious Diseases | Issue 1/2018

Abstract

Background

Aerococcus urinae is a gram-positive, alpha-hemolytic coccus bacterium primarily implicated in less than 1 % of all symptomatic urinary tract infections. Risk factors for disease include male gender, advanced age, and comorbid genitourinary tract pathology. Infections beyond the genitourinary tract are rare, though spondylodiscitis, perineal abscesses, lymphadenitis, bacteremia, meningitis, and endocarditis have been reported. Less than fifty cases of A. urinae infective endocarditis (IE) have been described in the literature. The rare occurrence of A. urinae in human infections and resultant lack of randomized controlled trials have resulted in a significant degree of clinical uncertainty in the management of A. urinae IE.

Case presentation

We present an unusual case of a forty-three year-old male with A. urinae infective endocarditis (IE) who was successfully treated with mitral valve replacement and six weeks of penicillin/gentamicin therapy. In addition, we include a comprehensive review of all reported cases of IE due to A. urinae with specific attention to therapeutic regimens and treatment durations.

Conclusion

Recent advances in diagnostic technology have led to an increase in the frequency A. urinae is diagnosed. Reviewing cases of Aerococcus urinae infections, their clinical courses and subsequent management can assist future healthcare providers and their patients.

Buchbinder, L., M. Solowey, and M. Solotorovsky. “Alpha hemolytic streptococci of air: their variant forms, origin and numbers per cubic foot of air in several types of locations.” [in eng]. Am J Public Health Nations Health 28, no. 1 1938 61–71.CrossRef

Williams, R. E., A. Hirch, and S. T. Cowan. “Aerococcus, a new bacterial genus.” [in eng]. J Gen Microbiol 8, no. 3 1953 475–480.CrossRef

Aguirre, M., and MD Collins. “Phylogenetic analysis of some Aerococcus-like organisms from urinary tract infections: description of Aerococcus Urinae Sp. Nov.” [in eng]. J Gen Microbiol 138, no. 2 1992 401–405.CrossRef

Rasmussen, M. “Aerococcus: an increasingly acknowledged human pathogen.” [in eng]. Clin Microbiol Infect 22, no. 1 2016 22–27.

Sunnerhagen, T., B. Nilson, L. Olaison, and M. Rasmussen. “Clinical and microbiological features of infective endocarditis caused by Aerococci.” [in eng]. Infection 44, no. 2 2016 167–173.

Rasmussen, M. “Aerococci and Aerococcal Infections.” [In eng]. J Infect 66, no. 6 2013 467–474.CrossRef

Senneby, E., A. C. Petersson, and M. Rasmussen. “Epidemiology and antibiotic susceptibility of Aerococci in urinary cultures.” [in eng]. Diagn Microbiol Infect Dis 81, no. 2 2015 149–151.CrossRef

Humphries, R. M., and J. A. Hindler. “In vitro antimicrobial susceptibility of Aerococcus Urinae.” [in eng]. J Clin Microbiol 52, no. 6 2014 2177–2180.CrossRef

Senneby, E., L. Goransson, S. Weiber, and M. Rasmussen. “A population-based study of Aerococcal Bacteraemia in the Maldi-Tof Ms-era.” [in eng]. Eur J Clin Microbiol Infect Dis 35, no. 5 2016 755–762.CrossRef

10.

Kass, M., B. Toye, and J. P. Veinot. “Fatal infective endocarditis due to Aerococcus Urinae—case report and review of literature.” [in eng]. Cardiovasc Pathol 17, no. 6 2008 410–412.CrossRef

11.

Melnick, S., S. Nazir, R. Hingorani, and P. Wexler. “Aerococcus Urinae, a rare cause of infective endocarditis.” [in eng]. BMJ Case Rep 2016 2016.

12.

de Jong, M. F., R. Soetekouw, R. W. ten Kate, and D. Veenendaal. “Aerococcus Urinae: severe and fatal bloodstream infections and endocarditis.” [in eng]. J Clin Microbiol 48, no. 9 2010 3445–3447.

13.

Tathireddy, H., S. Settypalli, and J. J. Farrell. “A rare case of Aerococcus Urinae infective endocarditis.” [in eng]. J Community Hosp Intern Med Perspect 7, no. 2 2017 126–129.CrossRef

14.

Tekin, A.G. Tekin, T. Turunc, Z. Demiroglu and O. Kizilkilic. “Infective Endocarditis and Spondylodiscitis in a Patient Due to Aerococcus Urinae: First Report.” [In eng]. Int J Cardiol 115, no. 3 2007 402–403.CrossRef

15.

Ebnother, C., M. Altwegg, J. Gottschalk, J. D. Seebach, and A. Kronenberg. “Aerococcus Urinae endocarditis: case report and review of the literature.” [in eng]. Infection 30, no. 5 2002 310–313.CrossRef

16.

Schuur, P. M., L. Sabbe, A. J. van der Wouw, G. J. Montagne, and A. G. Buiting. “Three cases of serious infection caused by Aerococcus Urinae.” [in eng]. Eur J Clin Microbiol Infect Dis 18, no. 5 1999 368–371.CrossRef

17.

Slany, M., T. Freiberger, P. Pavlik, and J. Cerny. “Culture-negative infective endocarditis caused by Aerococcus Urinae.” [in eng]. J Heart Valve Dis 16, no. 2 2007 203–205.

18.

Gompelman, M., W. Rozemeijer, and W. Kortmann. “A life-threatening complication of an ordinary urinary tract infection?” [in eng]. Neth J Med 72, no 9 2014 502, 05.

19.

Gritsch, W., M. Nagl, J. Hausdorfer, A. Gschwendtner, C. Pechlaner, and C. J. Wiedermann. “Septicaemia and Endomyocarditis caused by Aerococcus Urinae.” [in eng]. Wien Klin Wochenschr 111, no. 11 1999 446–447.

20.

Cattoir, V., A. Kobal, and P. Legrand. “Aerococcus Urinae and Aerococcus Sanguinicola, two frequently misidentified Uropathogens.” [in eng]. Scand J Infect Dis 42, no. 10 2010 775–780.CrossRef

21.

Opota, O., G. Prod’hom, C. Andreutti-Zaugg, M. Dessauges, L. Merz, G. Greub, J. P. Chave, and K. Jaton. “Diagnosis of Aerococcus Urinae infections: importance of matrix-assisted laser desorption ionization time-of-flight mass spectrometry and broad-range 16s Rdna Pcr.” [in eng]. Clin Microbiol Infect 22, no. 1 2016 e1-e2.CrossRef

22.

Meletis G, Chatzidimitriou D, Tsingerlioti F, Chatzopoulou F, Tzimagiorgis G. An initially unidentified case of urinary tract infection due to Aerococcus urinae. New Microbiol. 2017;30(3):221–2.

23.

Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 26^th ed. CLSI supplement M100S.

24.

Christensen JJ, Jansen IP, Faerk J, Kristensen B, Skov R, Korner B. Bacteremia/septicemia due to Aerocococcus-like organisms: report of seventeen cases. Clin Infect Dis. 1995;21:943–7.CrossRef

25.

Bruegger, D., A. Beiras-Fernandez, F. Weis, M. Weis, and F. Kur. “Extracorporeal support in a patient with cardiogenic shock due to Aerococcus Urinae endocarditis.” [in eng]. J Heart Valve Dis 18, no. 4 2009 418–420.

26.

Kristensen, B., and G. Nielsen. “Endocarditis caused by Aerococcus Urinae, a newly recognized pathogen.” [in eng]. Eur J Clin Microbiol Infect Dis 14, no. 1 1995 49–51.

27.

Zbinden, R., P. Santanam, L. Hunziker, B. Leuzinger, and A. von Graevenitz. “Endocarditis due to Aerococcus Urinae: diagnostic tests, fatty acid composition and killing kinetics.” [in eng]. Infection 27, no. 2 1999 122–124.

28.

Hirzel, C., L. Hirzberger, H. Furrer, and A. Endimiani. “Bactericidal activity of penicillin, ceftriaxone, gentamicin and Daptomycin alone and in combination against Aerococcus Urinae.” [in eng]. Int J Antimicrob Agents 48, no. 3 2016 271–276.CrossRef

29.

Alozie, A., C. Yerebakan, B. Westphal, G. Steinhoff, and A. Podbielski. “Culture-negative infective endocarditis of the aortic valve due to Aerococcus Urinae: a rare Aetiology.” [in eng]. Heart Lung Circ 21, no. 4 2012 231–233.CrossRef

30.

Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD. ACC/AHA task force members. 2014 AHA/ACC guideline for the Management of Patients with Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129(23):2440–92.CrossRef

31.

Baddour L, Wilson W, Bayer A, Fowler V, Tleyjah I, Rybak M, Barsic B, Lockhart P, Gewitz M, Levison M, Bolger A, Steckelberg J, Baltimore R, Fink A, O’Gara P, Taubert K. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and Management of Complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2013;132(15):1435–86.CrossRef

32.

Kotkar, K. D., S. M. Said, H. Michelena, B. Wanta, M. D. Fritock, and L. M. Baddour. “Right coronary artery septic embolization secondary to Aerococcus Urinae native mitral valve endocarditis.” [in eng]. Ann Thorac Surg 102, no. 4 2016 e295–e297.CrossRef

33.

Ho, E., J. Coveliers, B. J. Amsel, B. Stockman, J. Walpot, M. Ieven, and I. Rodrigus. “A case of endocarditis due to Aerococcus Urinae.” [in eng]. J Heart Valve Dis 19, no. 2 2010 264–266.

34.

Skov, R. L., M. Klarlund, and S. Thorsen. “Fatal endocarditis due to Aerococcus Urinae.” [in eng]. Diagn Microbiol Infect Dis 21, no. 4 1995 219–221.CrossRef

35.

Westmoreland, K., D. C. Halstead, and P. V. DuBose. “Infectious endocarditis in 49-year-old man and discussion of phenotypic characteristics of Aerococcus Urinae and Viridans streptococci.” [in eng]. Lab Med 45, no. 3 (Summer 2014): e101–e103.CrossRef

36.

Siddiqui, B., B. Chaucer, M. Chevenon, D. Fernandes, M. Rana, and J. Nfonoyim. “Aerococcus Urinae associated aortic and tricuspid valve infective endocarditis.” [in eng]. IDCases 4 (2016): 30–31.

Title: A rare case of Aerococcus urinae infective endocarditis in an atypically young male: case report and review of the literature
Authors: Joseph M. Yabes
Serafim Perdikis
David B. Graham
Ana Markelz
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI: https://doi.org/10.1186/s12879-018-3414-0

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

A rare case of Aerococcus urinae infective endocarditis in an atypically young male: case report and review of the literature

Abstract

Background

Case presentation

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Case presentation

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2018

The association between community-associated Staphylococcus aureus colonization and disease: a meta-analysis

Pre-industrial plague transmission is mediated by the synergistic effect of temperature and aridity index

Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults

A crowdsourced intervention to promote hepatitis B and C testing among men who have sex with men in China: study protocol for a nationwide online randomized controlled trial

30 years of dengue fatal cases in Brazil: a laboratorial-based investigation of 1047 cases

Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page